K
Kelly N. Godby
Researcher at University of Alabama at Birmingham
Publications - 60
Citations - 1787
Kelly N. Godby is an academic researcher from University of Alabama at Birmingham. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 14, co-authored 32 publications receiving 1101 citations. Previous affiliations of Kelly N. Godby include University of Alabama.
Papers
More filters
Journal ArticleDOI
Outcomes of patients with multiple myeloma refractory to CD38-targeted monoclonal antibody therapy.
Ujjawal H. Gandhi,Robert F. Cornell,Arjun Lakshman,Zhubin Gahvari,Elizabeth McGehee,Megan Jagosky,Ridhi Gupta,William Varnado,Mark A. Fiala,Saurabh Chhabra,Ehsan Malek,Joshua Mansour,Barry Paul,Alyssa Barnstead,Saranya Kodali,Amarendra K. Neppalli,Michaela Liedtke,Swapna Narayana,Kelly N. Godby,Yubin Kang,Ankit Kansagra,Elvira Umyarova,Emma C. Scott,Parameswaran Hari,Ravi Vij,Saad Z. Usmani,Natalie S. Callander,Shaji Kumar,Luciano J. Costa +28 more
TL;DR: Patients with MM refractory to CD38 MoAB have poor prognosis and this study provides benchmark for new therapies to be tested in this population.
Journal ArticleDOI
Multiple Myeloma, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology
Shaji Kumar,Natalie S. Callander,Melissa Alsina,Djordje Atanackovic,J. Sybil Biermann,Jason C. Chandler,Caitlin Costello,Matthew Faiman,Henry C. Fung,Cristina Gasparetto,Kelly N. Godby,Craig C. Hofmeister,Leona Holmberg,Sarah A. Holstein,Carol Ann Huff,Adetola A. Kassim,Michaela Liedtke,Thomas Martin,James L. Omel,Noopur Raje,Frederic J. Reu,Seema Singhal,George Somlo,Keith Stockerl-Goldstein,Steven P. Treon,Donna M. Weber,Joachim Yahalom,Dorothy A. Shead,Rashmi Kumar +28 more
TL;DR: The NCCN Multiple Myeloma Panel members have developed guidelines for the management of patients with various plasma cell dyscrasias, including solitary plasmacytoma, smoldering myeloma, multiple myelomas, systemic light chain amyloidosis, and Waldenström's macroglobulinemia.
Journal ArticleDOI
Recent trends in multiple myeloma incidence and survival by age, race, and ethnicity in the United States.
TL;DR: Findings confirm consistent improvement in survival for MM patients and point to the challenge of further extending these improvements to older and minority patients.
Journal ArticleDOI
Multiple myeloma, version 3.2021
Shaji Kumar,Natalie S. Callander,Kehinde Adekola,Larry D. Anderson,Muhamed Baljevic,Erica L. Campagnaro,Jorge J. Castillo,Jason C. Chandler,Caitlin Costello,Yvonne A. Efebera,Matthew Faiman,Alfred L. Garfall,Kelly N. Godby,Jens Hillengass,Leona Holmberg,Myo Htut,Carol Ann Huff,Yubin Kang,Malin Hultcrantz,Sarah Larson,Michaela Liedtke,Thomas Martin,James L. Omel,Kenneth H. Shain,Douglas W. Sborov,Keith Stockerl-Goldstein,Donna M. Weber,Jennifer Keller,Rashmi Kumar +28 more
TL;DR: This manuscript discusses the management of patients with solitary plasmacytoma, smoldering multiple Myeloma, and newly diagnosed multiple myeloma.
Journal ArticleDOI
Multiple myeloma, version 1.2020 featured updates to the NCCN guidelines
Shaji Kumar,Natalie S. Callander,Jens Hillengass,Michaela Liedtke,Muhamed Baljevic,Erica L. Campagnaro,Jorge J. Castillo,Jason C. Chandler,Robert F. Cornell,Caitlin Costello,Yvonne A. Efebera,Matthew Faiman,Alfred L. Garfall,Kelly N. Godby,Leona Holmberg,Myo Htut,Carol Ann Huff,Yubin Kang,Ola Landgren,Ehsan Malek,Thomas Martin,James L. Omel,Noopur Raje,Douglas W. Sborov,Seema Singhal,Keith Stockerl-Goldstein,Carlyn Rose C. Tan,Donna M. Weber,Alyse Johnson-Chilla,Jennifer Keller,Rashmi Kumar +30 more
TL;DR: The NCCN Guidelines for Multiple Myeloma as mentioned in this paper provide recommendations for diagnosis, workup, treatment, follow-up, and supportive care for patients with monoclonal gammopathy of renal significance.